Oxford Handbook of Practical Drug Therapy, 9780199562855
Paperback
Safe prescribing made easy: practical drug therapy at your fingertips.

$121.75

  • Paperback

    824 pages

  • Release Date

    21 November 2011

Check Delivery Options

Summary

The Prescriber’s Essential Guide: Oxford Handbook of Practical Drug Therapy

Safe and effective prescribing is crucial for proper patient care. With the increasing number of healthcare professionals now able to prescribe, having a comprehensive and accessible drug information resource is more important than ever.

The Oxford Handbook of Practical Drug Therapy bridges the gap by linking practical guidance on medicine use with concise details on drug pharmacology and the underly…

Book Details

ISBN-13:9780199562855
ISBN-10:0199562857
Series:Oxford Medical Handbooks
Author:Duncan Richards, Jamie Coleman, Jeffrey Aronson, D. John Reynolds
Publisher:Oxford University Press
Imprint:Oxford University Press
Format:Paperback
Number of Pages:824
Edition:2nd
Release Date:21 November 2011
Weight:410g
Dimensions:181mm x 107mm x 63mm
What They're Saying

Critics Review

This is a small compact and easy to utilise drug therapy manual,Overall a well set out easy to follow guide that would be useful for health professionals of all levels.

`Review from previous edition This is an ideal book to have on your person, and quickly refer to while on the wards. It does not claim to be a pharmacology textbook, or an encyclopedia of reported drug usage consequences, but a handbook - and whithin that role, it does the job superbly. It does what it says on the cover ‘practical drug therapy’. Those in their clinical years of medical school and perhaps house-officers would find this a usefulcompanion.‘Guy’s, Kings College, and St Thomas’ Hospitals (GKT) Gazette

About The Author

Duncan Richards

Duncan Richards trained in clinical pharmacology at Oxford where he developed a strong interest in translational pharmacology. Since completing his training, Duncan has worked in drug discovery for GSK. His current role is as Clinical Director of the Academic Discovery Performance Unit. This group aims to bring together the drug development expertise of GSK with the specialist knowledge of academic investigators to develop a portfolio of novel drug molecules.

Jeff Aronson is Reader in Clinical Pharmacology, University of Oxford, and Honorary Consultant Physician to the Oxford Radcliffe Hospitals NHS Trust. He does acute medical takes and teaches clinical students general medicine and practical drug therapy and prescribing. His research interests span all aspects of clinical pharmacology, especially adverse drug reactions and monitoring therapeutic interventions. He is President of the British Pharmacological Society, a member of the Formulary Committees of the British National Formulary and the British National Formulary for Children, a member of the Technology Appraisal Committee of NICE, Chairman of the British Pharmacopoeia Commission’s Expert Advisory Group on Nomenclature, and Editor-in-Chief of Meyler’s Side Effects of Drugs-The International Encyclopedia of Adverse Drug Reactions and Interactions (15th edition, 2006) and of its annual update volumes (Side Effects of Drugs Annuals).

Dr Jamie Coleman received his MBChB from the University of Birmingham in 1999. He trained in the West Midlands as a Clinical Pharmacologist undertaking an MD on the subject of adverse drug reactions which he completed in 2008. During his training he also developed an interest in medical teaching and gained an MA Medical Education in 2008. He took up a Consultant Clinical Pharmacologist job in early 2009 at the University Hospitals Birmingham NHS Foundation Trust and is an honorary senior lecturer in the College of Medical and Dental Sciences at the University of Birmingham. He continues to be involved in the teaching of therapeutics and prescribing to a wide variety of healthcare professionals at both undergraduate and postgraduate levels.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.